Browse EX-10 agreements

CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT

BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE

REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

Framework Cooperation Agreement

This Framework Cooperation Agreement (hereinafter referred to as this “Agreement”) is entered into by and between the following parties on September 26, 2025:

Party A:	III Company Registration Number:

Company Registration Number:  2056563        

Party B:	iitl., iit

Company Registration Number:  75862015        

In view of the resources and business advantages possessed by Party A and Party B in their respective industries, and for the purpose of jointly advancing market cooperation between both parties, Party A and Party B, following the principles of equality and voluntariness, have entered into this Framework Agreement through friendly consultation to set forth the fundamental terms of their cooperation.

I. Scope of Application and Legal Effect of this Framework Agreement

…

CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT
BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE
REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

Framework Cooperation Agreement

This Framework Cooperation Agreement (hereinafter referred to as “this Framework Agreement”) is entered into by Party A and Party B on September 22, 2025:

Party A:
Registered Address
Party B:
Registered Address

In view of the resources and business advantages possessed by Party A and Party B in their respective industries, and for the purpose of jointly expanding the market and conducting in-depth cooperation, Party A and Party B, following the principles of equality and voluntariness, have amicably negotiated and jointly entered into this Framework Agreement to establish the basic rules of cooperation and the rights and obligations of both parties.

I. Scope of Application and Legal Effect of This Framework Agreement

…

J.P. MORGAN REAL ESTATE INCOME TRUST, INC.

AMENDED AND RESTATED

INDEPENDENT DIRECTOR COMPENSATION POLICY

Effective Date

On May 14, 2026, the Board of Directors (the “Board”) of J.P. Morgan Real Estate Income Trust, Inc.(the “Company”) adopted this Amended and Restated Independent Director Compensation Policy (the “Policy”), to be effective as of July 1, 2026. This policy supersedes in its entirety that policy approved by the Board on June 1, 2022. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the J.P. Morgan Real Estate Income Trust, Inc.Independent Director Restricted Stock Plan (the “Plan”).

Eligibility

This Policy shall apply to directors of the Company who meet the requirements set forth for an “independent director” in the Company’s Charter.

Compensation

The following shall remain in effect until changed by the Board (collectively, the “Compensation”):

Annual Retainer:                $100,000

Audit Committee Chair Annual Retainer:    $10,000

Stock Ownership Policy

Each Independent Director shall be required to own Shares in an amount equal to 2.5 times his or her annual cash retainer within five years of becoming a member of the Board.

Payment Timing and Form

Audit Committee Chair Annual Retainer. The Audit Committee Chair Annual Retainer shall be paid quarterly in cash in arrears, taking into account any required proration as described below, as soon as possible following the end of the calendar quarter to which the Compensation relates.

…

FOURTH AMENDED AND RESTATED

LIMITED PARTNERSHIP AGREEMENT

OF

J.P. MORGAN REIT OPERATING PARTNERSHIP, L.P.

A DELAWARE LIMITED PARTNERSHIP

AUGUST 10, 2026

---

TABLE OF CONTENTS

Page

ARTICLE 1     DEFINED TERMS					1
1.1.    Definitions					1
1.2.    Interpretation					13
ARTICLE 2     PARTNERSHIP FORMATION AND IDENTIFICATION					13

…

THIRD AMENDED AND RESTATED

LIMITED PARTNERSHIP AGREEMENT

OF

J.P. MORGAN REIT OPERATING PARTNERSHIP, L.P.

A DELAWARE LIMITED PARTNERSHIP

APRIL 17, 2026

LEGAL/51094661v2

---

TABLE OF CONTENTS

Page

ARTICLE 1     DEFINED TERMS					1
1.1.    Definitions					1
1.2.    Interpretation					13
ARTICLE 2     PARTNERSHIP FORMATION AND IDENTIFICATION					13

…

FIFTH AMENDED AND RESTATED ADVISORY AGREEMENT

AMONG

J.P. MORGAN REAL ESTATE INCOME TRUST, INC.,

J.P. MORGAN REIT OPERATING PARTNERSHIP, L.P.,

AND

J.P. MORGAN INVESTMENT MANAGEMENT INC.

---

TABLE OF CONTENTS

								Page
1.						DEFINITIONS	1
2.						APPOINTMENT	6
3.						DUTIES OF THE ADVISER	6
4.						AUTHORITY OF ADVISER	8
5.						BANK ACCOUNTS	9
6.						RECORDS; ACCESS	10
7.						LIMITATIONS ON ACTIVITIES	10
8.						OTHER ACTIVITIES OF THE ADVISER	10
9.						RELATIONSHIP WITH DIRECTORS AND OFFICERS	12

…

MONOPAR THERAPEUTICS INC.

2026 Stock Incentive Plan

RESTRICTED STOCK UNIT GRANT NOTICE

Monopar Therapeutics Inc. (the “Company”) has awarded to Awardee the number of restricted stock units under its 2026 Stock Incentive Plan (the “Plan”) set forth below (the “Award”).

Awardee:		[[firstname]] [[lastname]]
Date of Grant:		[[grantdate]]

…

MONOPAR THERAPEUTICS INC.

2026 Stock Incentive Plan

NONQUALIFIED STOCK OPTION AGREEMENT

THIS NONQUALIFIED STOCK OPTION AGREEMENT (this “Agreement”) is made as of [[grantdate]] (the “Grant Date”) between MONOPAR THERAPEUTICS INC. (the “Company”) and [[firstname]] [[lastname]] (referred to herein as “Participant”). Terms used in this Agreement with initial capital letters without definitions are defined in the Monopar Therapeutics Inc. 2026 Stock Incentive Plan (the “Plan”) and have the same meaning in this Agreement.

The Participant and the Company are entering into this Agreement with the understanding that the options granted hereunder are granted in full satisfaction of any and all prior oral and/or written commitments from the Company to grant to Participant options to purchase shares of the Company.

1.        Option Shares. On the Grant Date, the Company hereby grants to Participant the option (the “Option”) to purchase up to [[sharesgranted]] shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), pursuant and subject to the terms of the Plan, a copy of which has been delivered or made available to Participant and is incorporated herein by reference. The Option granted hereby is a Nonqualified Stock Option.

2.        Exercise Price. The purchase price per Share upon exercise of the Option is [[grantprice]].

…

MONOPAR THERAPEUTICS INC.

2026 Stock Incentive Plan

INCENTIVE STOCK OPTION AGREEMENT

THIS INCENTIVE STOCK OPTION AGREEMENT (this “Agreement”) is made as of **[[grantdate]] **(the “Grant Date”) between MONOPAR THERAPEUTICS INC. (the “Company”) and [[firstname]] [[lastname]] (referred to herein as “Participant”). Terms used in this Agreement with initial capital letters without definitions are defined in the Monopar Therapeutics Inc. 2026 Stock Incentive Plan (the “Plan”) and have the same meaning in this Agreement.

1.    Option Shares. On the Grant Date, the Company hereby grants to Participant the option (the “Option”) to purchase [[sharesgranted]] shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), pursuant and subject to the terms of the Plan, a copy of which has been delivered or made available to Participant and is incorporated herein by reference. The Option granted hereby is an Incentive Stock Option.

2.    Exercise Price. The purchase price per Share upon exercise of the Option is [[grantprice]].

3.    Vesting. Subject to the terms of the Plan, the Option shall vest and be exercisable only during the period beginning at the Grant Date and ending 10 years after the Grant Date (the “Grant Expiration Date”). During such period, provided that Participant continues to be an Employee of the Company or a Subsidiary, the Option shall vest and become exercisable (i.e., shares of Common Stock may be purchased) according to the following schedule:

Vesting Start Date: [[vestingstartdate]]

…

Execution Version

AMENDMENT NO. 1 TO CREDIT AGREEMENT

This Amendment No. 1 to Credit Agreement, dated as of August 12, 2026 (this “Amendment”), to the Credit Agreement, dated as of February 12, 2026 (as amended, restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”; the Credit Agreement, as amended by this Amendment is herein referred to as the “Amended Credit Agreement”), among Alkermes plc, a company incorporated under the laws of Ireland (registered number 498284) (the “TopCo Borrower”), Alkermes, Inc., a Pennsylvania corporation and an indirect wholly-owned subsidiary of the TopCo Borrower (the “U.S. Borrower”), Alkermes Finance LLC, a Delaware limited liability company and an indirect wholly-owned subsidiary of the TopCo Borrower (the “U.S. Co-Borrower” and together with the U.S. Borrower and the TopCo Borrower, each a “Borrower” and, collectively, the “Borrowers”), the lenders from time to time party theretoand JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”), is entered into by and among the Borrowers, each of the Subsidiary Guarantors party hereto (with respect to Section 6hereof), the 2026 Refinancing Tranche B Term Lenders (as defined below), the Initial Tranche A Term Lenders (constituting all of the Initial Tranche A Term Lenders) and the Administrative Agent. Terms defined in the Credit Agreement or the Amended Credit Agreement, as applicable, shall be used in this Amendment with their defined meanings therein unless otherwise defined herein.

…

** **

Form of Vertical Data Inc.

** **

Subscription Agreement

** **

Shares of Common Stock

** **

This Subscription Agreement (this “Agreement”) made as of _______, 2026, is by and between Vertical Data, Inc., a corporation organized and existing under the laws of the State of Nevada (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers” or the “undersigned”).

WHEREAS, subject to the terms and conditions set forth in this Agreement, and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), Rule 506 promulgated under the Securities Act (“Rule 506”), and/or Regulation S under the Securities Act (“Regulation S”), the Company desires to issue and sell to each Purchaser, and each Purchaser desires to purchase from the Company, that number of shares (the “Shares” or the “Investment Securities”) of the Company’s common stock, par value $0.0001 per share (the “common stock”), set forth on the signature page hereto, to U.S. Purchasers who are “accredited investors” (as defined in Rule 501 of Regulation D under the Securities Act), and any non-accredited investors only if permitted under Rule 506 and to persons who are not U.S. Persons (as defined below) under Regulation S and definitive documentation in a private placement (the “Offering”); and

…

AMENDMENT NO. 4

TO THE

INVESTMENT MANAGEMENT TRUST AGREEMENT

This Amendment No. 4 (this “Amendment”), dated as of August 11, 2026, to the Investment Management Trust Agreement (as defined below) is made by and between Embrace Change Acquisition Corp. (the “Company”) and Continental Stock Transfer & Trust Company, as trustee (“Trustee”). All terms used but not defined herein shall have the meanings assigned to them in the Trust Agreement.

WHEREAS, the Company and the Trustee entered into an Investment Management Trust Agreement dated as of August 9, 2022 (the “Trust Agreement”):

WHEREAS, Section l(i) of the Trust Agreement sets forth the terms that govern the liquidation of the Trust Account under the circumstances described therein;

WHEREAS, the Amendment No. 3 of the Trust Agreement amended the Last Date from August 12, 2025 to August 12, 2026 and the Company is not required to make any deposit into the Trust Account for the extension of the twelve months;

WHEREAS, at an Extraordinary General Meeting of the Company held on August 11, 2026 (the “Extraordinary General Meeting”), the Company’s shareholders approved (i) a proposal to amend the Company’s amended and restated articles of association (the “A&R AA”) giving the Company the right to extend the date by which it has to consummate a business combination twelve (12) months, from August 12, 2026 to August 12, 2027 (i.e., for a period of time ending 60 months from the consummation of its initial public offering); and (ii) a proposal to amend the Trust Agreement accordingly; and

…